Cen Xu
18Patents
4h-index
20Co-inventors
56Inventor score
Filing activity: Dec 18, 2009 → Dec 21, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9102731B2 | Human CGRP receptor binding proteins | Physics | 22 | Active |
| US9365653B2 | Human PAC1 antibodies | Chemistry; Metallurgy | 20 | Active |
| US10822408B2 | PACAP antibodies and uses thereof | Chemistry; Metallurgy | 10 | Active |
| US9862771B2 | Human CGRP receptor binding proteins | Physics | 7 | Active |
| US10053507B2 | Human PAC1 antibodies | Chemistry; Metallurgy | 3 | Active |
| US9822178B2 | Human PAC1 antibodies | Chemistry; Metallurgy | 3 | Active |
| US10934362B2 | Bi-specific anti-CGRP receptor/PAC1 receptor antigen binding proteins and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US9676851B2 | Human PAC1 antibodies | Chemistry; Metallurgy | 3 | Active |
| US10738110B2 | PAC1 antibodies and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US11248043B2 | Methods for treating a headache condition using anti-human PAC1 antibodies or antigen-binding fragments thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US10472417B2 | Human PAC1 antibodies | Chemistry; Metallurgy | 0 | Active |
| US11891435B2 | Polynucleotides encoding monoclonal antibodies binding to human pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1) and methods of making thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US10294298B2 | Human PAC1 antibodies | Chemistry; Metallurgy | 0 | Active |
| US10793631B2 | Human PAC1 antibodies | Chemistry; Metallurgy | 0 | Active |
| US11919964B2 | Bi-specific anti-CGRP receptor/PAC1 receptor antigen binding proteins and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12122841B2 | Human CGRP receptor binding proteins | Physics | 0 | Active |
| US11780914B2 | PACAP antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12134652B2 | Human CGRP receptor binding proteins | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.